Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

You may be eligible if

• DISEASE CHARACTERISTICS:
• Histologically confirmed ovarian epithelial, fallopian tube, or peritoneal cancer
• * Stage II-IV
• Initially treated with surgery and at least 1 platinum-based chemotherapy regimen
• Must have relapsed after initial treatment and completed chemotherapy for recurrent disease
• Asymptomatic residual measurable disease on CT scan and/or an elevated CA 125 allowed
• Complete clinical remission allowed, defined by the following criteria:
• * CA 125 no greater than 35 IU/mL
• * No objective evidence of disease by CT scan
• * Normal physical examination
• PATIENT CHARACTERISTICS:
• Age
• 18 and over
• Performance status
• Karnofsky 70-100%
• Life expectancy
• At least 3 months
• Hematopoietic
• WBC at least 1,500/mm\^3
• Platelet count at least 100,000/mm\^3
• Hemoglobin at least 10 g/dL
• Hepatic
• Bilirubin no greater than 2 times normal
• ALT no greater than 2 times normal
• Alkaline phosphatase no greater than 2 times normal
• Renal
• Creatinine no greater than 1.5 times normal
• Other
• Not pregnant or nursing
• No potential for child bearing
• Human antimurine antibody negative
• HIV negative
• No other malignancy within the past 5 years except nonmelanoma skin cancer or carcinoma in situ of the cervix
• No active infection
• No known autoimmune disease (e.g., rheumatoid arthritis or ulcerative colitis)
• No known immune deficiency (e.g., hypogammaglobulinemia)
• No known allergy to murine proteins
• PRIOR CONCURRENT THERAPY:
• Biologic therapy
• At least 6 weeks since prior interferon
• At least 6 weeks since prior immunotherapy or biological response modifiers
• No prior anticancer vaccine
• Chemotherapy
• See Disease Characteristics
• At least 3 weeks since prior cytotoxic or investigational chemotherapy
• Endocrine therapy
• No concurrent steroids
• Radiotherapy
• At least 4 weeks since prior radiotherapy
• Surgery
• See Disease Characteristics
• Other
• At least 1 week since prior antibiotics
• No concurrent cyclosporine
• No other concurrent immunosuppressive therapy